Search

everythinglearnresearchcommunity

for

Search:↓

2011 dermatological research found new skin aging markers, hair loss causes, skin defense mechanisms, and potential for new treatments.

Opioid painkillers can cause many side effects, including breathing problems and addiction, but are generally considered safe when used properly.

The Accu-Chek FlexLink Plus and Accu-Chek LinkAssist Plus make insulin pump use safer, simpler, and more comfortable.

Fusion proteins can protect hair from heat damage.

Cosmeceuticals may benefit skin health but need more research for efficacy and safety confirmation.

Children taking higher doses of valproic acid had lower biotinidase activity, which may lead to biotin deficiency, but biotin supplements could help.

Restoring mitochondrial function in mice reversed their skin wrinkling and hair loss.

A(1-7) treatment reduces symptoms of lupus in mice.

Excluding alopecia and mucous membrane components from the CLASI-A score reduces its effectiveness in capturing important disease activity.

Combination therapy with QR 678 Neo and 5% Minoxidil is most effective for male hair loss.

Cholesterol-modified siRNAs targeting certain genes increased hair growth in mice.

Nanocarriers like liposomes and cyclodextrins improve how angiotensin-(1-7) is delivered in the body.

Hair graying is caused by the loss of pigment cells due to poor maintenance of stem cells in the hair follicle.

Sweating can potentially be controlled through olfactory receptors, with β-ionone playing a key role, and responses may vary between genders.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

The document does not confirm if radical prostatectomy is the best treatment for locally advanced prostate cancer.

ZDHHC13 is important for normal liver function and metabolism, affecting mitochondrial activity.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

Sphinganine can reduce hair loss and improve scalp health.

Metabolic syndrome's individual issues are real and need treatment to reduce diabetes and heart disease risks.

New pharmaceutical biomaterials, especially nanomaterials, show promise for improving cancer treatment and disease diagnosis.

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

Scalp Threading is a promising new treatment for hair loss that may work better than current options.

Hydra can help understand human hair follicle microbiomes and develop new skin disease therapies.

Machine learning is effective in predicting gene functions and their relationships with diseases.

This enzyme helps metabolize fatty acids and isoleucine, and could be key in treating neurological diseases and certain cancers.

Editing the FGF5 gene in sheep increases wool length, confirming its role in hair growth.

Uncombable hair syndrome causes frizzy hair and can affect the nervous system, eyes, and ears, often co-occurring with other hair, skin, nail, and teeth conditions, and is linked to three specific gene mutations.

FERONIA and LRX proteins help control cell growth in plants by regulating vacuole expansion.